scispace - formally typeset
Open AccessJournal ArticleDOI

COVID-19 and metabolic disease: mechanisms and clinical management.

Reads0
Chats0
TLDR
In this paper, the authors provide an update on the mechanisms of how metabolic and endocrine disorders might predispose patients to develop severe COVID-19 and post-pandemic.
About
This article is published in The Lancet Diabetes & Endocrinology.The article was published on 2021-10-04 and is currently open access. It has received 119 citations till now. The article focuses on the topics: Diabetes mellitus & Disease.

read more

Citations
More filters
Journal ArticleDOI

Risks and burdens of incident diabetes in long COVID: a cohort study

TL;DR: In this paper , the authors examined the post-acute risk and burden of incident diabetes in people who survived the first 30 days of SARS-CoV-2 infection.
Journal ArticleDOI

Risks and burdens of incident diabetes in long COVID: a cohort study

TL;DR: Increased risks and 12-month burdens of incident diabetes and antihyperglycaemic use in people with COVID-19 compared with a contemporary control group of people who were enrolled during the same period and had not contracted SARS-CoV-2, and a historical control group from a pre-pandemic era are reported.
Journal ArticleDOI

The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus

- 12 Jan 2022 - 
TL;DR: In this paper , the authors characterized the K18-hACE2 mouse model expressing human (h)ACE2 in mice, controlled by the human keratin 18 (K18) promoter in the epithelia, including airway epithelial cells where SARS-CoV-2 infections typically start.
Journal ArticleDOI

Sexual dimorphism in COVID-19: potential clinical and public health implications

TL;DR: Zhou et al. as mentioned in this paper discussed how sex hormones, comorbidities, and the sex chromosome complement influence these mechanisms in the context of COVID-19 and suggested that sex differences could be considered in future pandemic surveillance and treatment of patients with COVID19 to help to achieve better disease stratification and improved outcomes.
References
More filters
Journal ArticleDOI

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.

TL;DR: It is demonstrating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination, and it is shown that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of Sars- coV- 2 S and SARS S bind with similar affinities to human ACE2, correlating with the efficient spread of SATS among humans.
Journal ArticleDOI

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.

TL;DR: High-resolution crystal structures of the receptor-binding domain of the spike protein of SARS-CoV-2 and SARS -CoV in complex with ACE2 provide insights into the binding mode of these coronaviruses and highlight essential ACE2-interacting residues.
Journal ArticleDOI

Dexamethasone in Hospitalized Patients with Covid-19

TL;DR: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.